Grigutsch V
Bundesministerium für Gesundheit, Bonn.
Infusionsther Transfusionsmed. 1994 Nov;21 Suppl 3:12-5.
The European institutions have been dealing with blood and blood products since 1956. A need for action currently exists with regard to the European Community's Directive 89/381/EEC. The aims of the Directive are: the elaboration of strict quality and safety criteria for medicinal products made from human blood and blood products, with special reference to preventing the transmission of viral diseases, and the demand for self-sufficiency within the European Community in human blood and blood products on the basis of voluntary and unremunerated blood donations. In May 1993, the Commission submitted a report on the implementation of this Directive. In principle, the Member States are in agreement that self-sufficiency on the basis of unremunerated donations should be achieved. Differences of opinion exist, however, with respect to the national self-sufficiency of each Member State and the definition of 'unremunerated'. Germany's standpoints enjoy greater acceptance today than they did only a few years ago; consequently, there is reason to assume that, even in the wake of developments within the European Community, the basic structures of the blood and blood products supply system in the Federal Republic of Germany will be maintained.
自1956年以来，欧洲各机构一直在处理血液及血液制品相关事务。目前，针对欧共体第89/381/EEC号指令有采取行动的必要。该指令的目标是：制定严格的人血及血液制品制成的药品质量和安全标准，特别强调预防病毒性疾病的传播，并要求欧共体在自愿无偿献血的基础上实现人血及血液制品的自给自足。1993年5月，委员会提交了一份关于该指令实施情况的报告。原则上，成员国一致认为应在无偿献血的基础上实现自给自足。然而，在各成员国的国家自给自足情况以及“无偿献血”的定义方面存在意见分歧。如今，德国的立场比几年前更受认可；因此，有理由认为，即使在欧共体内部发展的情况下，德意志联邦共和国血液及血液制品供应系统的基本结构仍将得以维持。
